Cathrin Sellmann1, Cheng Jun Jin1, Anna Janina Engstler1, Jean-Pascal De Bandt2,3, Ina Bergheim4. 1. Institute of Nutritional Sciences, SD Model Systems of Molecular Nutrition, Friedrich-Schiller University Jena, Dornburger Str. 29, 07743, Jena, Germany. 2. Nutrition Biology Laboratory EA4466, Faculty of Pharmacy, Paris Descartes University, Sorbonne Paris Cité, Paris, France. 3. Clinical Chemistry Department, Paris Centre University Hospitals, APHP, Paris, France. 4. Institute of Nutritional Sciences, SD Model Systems of Molecular Nutrition, Friedrich-Schiller University Jena, Dornburger Str. 29, 07743, Jena, Germany. ina.bergheim@uni-jena.de.
Abstract
PURPOSE: Impairments of intestinal barrier function are discussed as risk factors for the development and progression of non-alcoholic fatty liver disease (NAFLD). Studies suggest an association between arginine/citrulline homeostasis and the development of liver damages. Here, the effect of an oral L-citrulline (Cit) supplement on the development of a Western-style diet (WSD)-induced NAFLD was determined in mice. METHODS: Female 6- to 8-week-old C57BL/6J mice were either pair-fed a liquid Western-style or control diet (C) ± 2.5 g/kg bodyweight Cit for 6 weeks (C + Cit or WSD + Cit). Indices of liver damage, glucose metabolism, intestinal barrier function and NO synthesis were measured. RESULTS: While bodyweight gain was similar between groups, markers of glucose metabolism like fasting blood glucose and HOMA index and markers of liver damage like hepatic triglyceride levels, number of neutrophils and plasminogen activator inhibitor-1 protein levels were significantly lower in WSD + Cit-fed mice when compared to WSD-fed mice only. Protein levels of the tight junction proteins occludin and zonula occludens-1 in duodenum were significantly lower in mice fed a WSD when compared to those fed a WSD + Cit (-~70 and -~60 %, respectively, P < 0.05), whereas portal endotoxin levels, concentration of 3-nitrotyrosine protein adducts in duodenum and toll-like receptor-4 mRNA expression in livers of WSD + Cit-fed mice were markedly lower than in WSD-fed mice (-~43 %, P = 0.056; -~80 and -~48 %, respectively, P < 0.05). CONCLUSION: Our data suggest that the protective effects of supplementing Cit on the development of NAFLD in mice are associated with a decreased translocation of endotoxin into the portal vein.
PURPOSE: Impairments of intestinal barrier function are discussed as risk factors for the development and progression of non-alcoholic fatty liver disease (NAFLD). Studies suggest an association between arginine/citrulline homeostasis and the development of liver damages. Here, the effect of an oral L-citrulline (Cit) supplement on the development of a Western-style diet (WSD)-induced NAFLD was determined in mice. METHODS: Female 6- to 8-week-old C57BL/6J mice were either pair-fed a liquid Western-style or control diet (C) ± 2.5 g/kg bodyweight Cit for 6 weeks (C + Cit or WSD + Cit). Indices of liver damage, glucose metabolism, intestinal barrier function and NO synthesis were measured. RESULTS: While bodyweight gain was similar between groups, markers of glucose metabolism like fasting blood glucose and HOMA index and markers of liver damage like hepatic triglyceride levels, number of neutrophils and plasminogen activator inhibitor-1 protein levels were significantly lower in WSD + Cit-fed mice when compared to WSD-fed mice only. Protein levels of the tight junction proteins occludin and zonula occludens-1 in duodenum were significantly lower in mice fed a WSD when compared to those fed a WSD + Cit (-~70 and -~60 %, respectively, P < 0.05), whereas portal endotoxin levels, concentration of 3-nitrotyrosine protein adducts in duodenum and toll-like receptor-4 mRNA expression in livers of WSD + Cit-fed mice were markedly lower than in WSD-fed mice (-~43 %, P = 0.056; -~80 and -~48 %, respectively, P < 0.05). CONCLUSION: Our data suggest that the protective effects of supplementing Cit on the development of NAFLD in mice are associated with a decreased translocation of endotoxin into the portal vein.
Authors: Astrid Spruss; Janin Henkel; Giridhar Kanuri; Daniela Blank; Gerhard P Püschel; Stephan C Bischoff; Ina Bergheim Journal: Mol Med Date: 2012-12-06 Impact factor: 6.354
Authors: Karolina A P Wijnands; Hans Vink; Jacob J Briedé; Ernst E van Faassen; Wouter H Lamers; Wim A Buurman; Martijn Poeze Journal: PLoS One Date: 2012-05-29 Impact factor: 3.240
Authors: Victoria Anthony Uyanga; Felix Kwame Amevor; Min Liu; Zhifu Cui; Xiaoling Zhao; Hai Lin Journal: Nutrients Date: 2021-10-25 Impact factor: 5.717
Authors: Victoria Anthony Uyanga; Emmanuel O Oke; Felix Kwame Amevor; Jingpeng Zhao; Xiaojuan Wang; Hongchao Jiao; Okanlawon M Onagbesan; Hai Lin Journal: J Anim Sci Biotechnol Date: 2022-03-10
Authors: Cathrin Sellmann; Christian Degen; Cheng Jun Jin; Anika Nier; Anna Janina Engstler; Dana Hasan Alkhatib; Jean-Pascal De Bandt; Ina Bergheim Journal: Amino Acids Date: 2017-04-22 Impact factor: 3.520